CDRE — Cadre Holdings, Inc.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1860543 ·
Last close
$32.41
Market Cap
$1.39B
52W High
$48.28
52W Low
$23.99
ADV30
481,469
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 202,876,000 | 88,091,000 | 29,214,000 | 15,985,000 | 922,694,000 | 63,916,000 | 555,912,000 |
| Jun 2026 | 207,126,000 | 87,135,000 | 23,915,000 | 11,407,000 | 917,298,000 | 53,984,000 | 570,496,000 |
| Mar 2026 | 155,429,000 | 60,166,000 | 9,333,000 | 1,975,000 | 879,736,000 | 41,272,000 | 543,620,000 |
| Dec 2025 | 167,224,000 | 72,623,000 | 21,896,000 | 11,739,000 | 770,031,000 | 122,898,000 | 452,227,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$88,835,000
Investing CF
$-177,826,000
Financing CF
$6,360,000
CapEx
$-12,478,000
Dividends Paid
$-16,708,000
Buybacks
—
EPS Diluted TTM
$0.95
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$51,293,000
Inventory
$126,668,000
Receivables
$127,082,000
ST Investments
—
EBIT TTM
$79,666,000
Pretax Income TTM
$61,340,000
Interest Exp TTM
$18,326,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$732,654,976
EBITDA
$114,964,000
Free Cash Flow
$56,777,248
Enterprise Value
$1,728,196,864
Total Cash
$65,326,000
Total Debt
$394,303,008
Shares Out
42,920,853
Trailing EPS
$0.91
Book Value
$8.55
ROE
11.6%
ROA
6.7%
Div Yield
1.23%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 610,308,000 | 75,047,000 | 44,139,000 | 770,031,000 | 452,227,000 | 317,804,000 | 63,705,000 |
| Dec 2024 | 567,561,000 | 72,768,000 | 36,133,000 | 652,713,000 | 341,198,000 | 311,515,000 | 31,777,000 |
| Dec 2023 | 482,532,000 | 58,711,000 | 38,641,000 | 431,179,000 | 234,017,000 | 197,162,000 | 73,209,000 |
| Dec 2022 | 457,837,000 | 21,071,000 | 5,820,000 | 391,952,000 | 226,062,000 | 165,890,000 | 46,409,000 |
TTM Snapshot
Revenues TTM
$685,648,000
NetIncome TTM
$36,062,000
OpCashFlow TTM
—
Assets (Latest)
$917,298,000
Forward EPS
$1.64
Max Pain — expiry 2027-04-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $25.00 · spot: $31.88 · call volume: 5 · put volume: 19
Expected Move to 2027-04-16:
±$8.15
(25.56%) —
implied range
$23.73 –
$40.03
· ATM straddle on $30.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PRCT | PROCEPT BioRobotics Corp | $1.37B | $23.78 | — |
| BFLY | Butterfly Network, Inc. | $1.41B | $5.75 | — |
| CNMD | CONMED Corp | $1.44B | $48.39 | — |
| NVCR | NovoCure Ltd | $1.30B | $11.14 | — |
| ENOV | Enovis CORP | $1.57B | $27.22 | — |
News headlines (Yahoo Finance, 1h cache)
Top consumer products stock to watch: B Riley
2026-11-17 20:02 · Yahoo
Cadre Holdings Announces Chief Financial Officer Transition
2026-11-16 13:00 · Yahoo
5 insightful analyst questions from Cadre’s Q3 2026 earnings call
2026-11-09 02:05 · Yahoo
Cadre Holdings (CDRE) After Strong Earnings And A Buyback Looks Undervalued
2026-11-07 19:13 · Yahoo
What Cadre (CDRE) Said on Its Q3 Earnings Call
2026-11-07 07:14 · Yahoo
How Investors May Respond To Cadre Holdings (CDRE) Raised Outlook And Buyback
2026-11-06 17:18 · Yahoo
Cadre Holdings Inc (CDRE) (Q3 2026) Earnings Call Highlights: 30% Sales Surge, Raised Guidance ...
2026-11-06 03:09 · Yahoo
Cadre Holdings (CDRE) Q3 2026 Earnings Call Transcript
2026-11-05 22:58 · Yahoo
Cadre Holdings, Inc. Q3 2026 Earnings Call Summary
2026-11-05 13:30 · Yahoo
Cadre Holdings, Inc. (CDRE) Reports Q3 Earnings: What Key Metrics Have to Say
2026-11-05 00:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.